Clinical Research

New meta-analysis explores potential of endovascular treatments for long femoropopliteal lesions
Open surgical bypass is the gold standard, but endovascular therapies may provide value for high-risk patients with long femoropopliteal lesions.
Less than 25% of radiology-related NIH grants have been awarded to female researchers
New findings highlight the lingering issue of gender inequity in the field, the effects of which extend well beyond career growth for women.
Men developed CVD earlier than women, according to 35-year CARDIA study
Promoting preventive care among young adult men during critical periods of their life may be the key to reducing rates of cardiovascular disease.
Comparable long-term survival seen in two common CABG strategies
STS late-breaking study found BITA and SITA+RA have similar long-term survival, but age plays a role in which to choose.
Patients with paradoxical low-flow, low gradient AS linked to higher mortality rate after TAVR
Patients with this specific subtype of severe aortic stenosis, which can sometimes be challenging to diagnose, face a number of additional risks.

An 86-year-old patient is showing signs of improvement six months after receiving the world’s first implant of a new-look medical device for treating tricuspid regurgitation (TR), according to new data published in JACC: Cardiovascular Interventions.[1] The device in question, the Tricuspid Flow Optimizer, was developed by Triflo Cardiovascular, a U.S.-based biomedical company founded in 2017 by a team of structural heart specialists.

Cardiologists share update after world’s first implant of new optimizer device for tricuspid regurgitation

The Tricuspid Flow Optimizer was developed by Triflo Cardiovascular, a U.S.-based healthcare technology company founded by structural heart specialists.

Could diamond dust replace gadolinium in MRI contrast agents?

An accidental discovery could have future implications for the material makeup for MRI contrast media.

Statin therapy may help HFpEF patients lower their risk of death, heart attack or stroke

All participants were free of ASCVD and had no history of statin use at the start of the study.

New PET technique spots 'smoldering' changes not visible on MRI in the brains of MS patients

The new technique uncovers hidden inflammation in patients who, despite undergoing extensive treatment for the condition, had worsening symptoms.

old elderly couple coffee drink retired love romance man

TAVR, SAVR linked to similar QOL improvements for intermediate-risk patients after five years

TAVR was initially associated with greater benefits than surgery, but that difference faded by the end of the first year.

Rad techs helpfully ‘stand in a surgeon’s shoes’ thanks to virtual reality

Johns Hopkins researchers demonstrated the worthiness of the concept this year.

Video of James Januzzi explaining the results of a new diabetic cardiomyopathy treatment in ACC 2024 late-breaking ARISE-HF trial. #ACC #ACC24 #ACC2024

Diabetic cardiomyopathy treatment shows promise in ARISE-HF

James Januzzi Jr., MD, said the treatment's overall impact was neutral, but he and his team saw "a very clear and encouraging signal."

Alzheimer’s imaging experts to assess utility, efficiency of Hyperfine’s Swoop system

Is portable MRI suitable for finding abnormalities in the brains of patients receiving new amyloid-targeting therapy for Alzheimer’s disease? Clinical researchers are about to find out.

Clinical Research

New meta-analysis explores potential of endovascular treatments for long femoropopliteal lesions

Less than 25% of radiology-related NIH grants have been awarded to female researchers

Men developed CVD earlier than women, according to 35-year CARDIA study

Comparable long-term survival seen in two common CABG strategies

Patients with paradoxical low-flow, low gradient AS linked to higher mortality rate after TAVR